Aptar Pharma Continues Global Expansion with North America Capacity Extension

Aptar today announced the next phase of its global capacity expansion plan in North America, at its Aptar Congers, New York site. This investment will help Aptar meet the growing prescription and consumer healthcare customer demand for proprietary drug delivery systems in North America. The North America Capacity Extension will benefit local customers.

Manufacturing began at Aptar Congers in 2002 with a cleanroom and the production of Aptar Pharma’s VP3 pumps, and today the site manufactures a wide range of proprietary drug delivery products for nasal and injectable delivery routes. Manufacturing capabilities at the Congers facility will be further expanded to offer even more innovative product solutions and increased production capacity to Aptar Pharma customers in North America.

To support increasing patient demand for systemic nasal delivery, Aptar Pharma is significantly expanding the manufacturing capacity of its proprietary Unidose (UDS) Nasal Spray Systems via the addition of molds and assembly lines in cleanroom manufacturing settings, with the additional capacity planned to come online in Q4 2024.
more at: https://aptar.com/news-events/aptar-pharma-continues-global-expansion-with-north-america-capacity-extension/

Related Posts

Atlantic Packaging has partnered with TOM FORD and Lonely Whale to accelerate the adoption of seaweed-based plastic alternatives.

Nearly half of all new plastic waste entering the ocean each year comes from one ubiquitous source: thin-film plastic made from fossil fuels, that are extracted from the ground, releasing harmful carbon into the atmosphere and displacing wildlife and people from their homes. These flexible films are not readily degradable and difficult to recycle — they can often end up in the ocean, where they can be ingested by sea life. In 2020, Lonely Whale, a nonprofit whose mission is to keep plastic out of oceans, unveiled “Unwrap the Future,” a three phase, multi-year program to vet and scale viable, marine-safe solutions to traditional thin-film plastic. For phase one of the program, the TOM FORD Plastic Innovation Prize was created in partnership with Lonely Whale and TOM FORD, a luxury fashion house.

Berry Global Announces Review of Strategic Alternatives for its Health, Hygiene and Specialties Segment

Berry Global Group, Inc. announced that it has initiated a formal process to evaluate strategic alternatives for its Health, Hygiene and Specialties segment (“HH&S”). HH&S is a leading provider of nonwovens, specialty films, and tapes for a broad range of end markets, including healthcare, hygiene, consumer, building and construction, and industrials. The segment is well-positioned in its core businesses, providing value-added products to many of the world’s leading brand owners. The Company is considering a wide range of available alternatives to maximize shareholder value, including, but not limited to, a sale, strategic partnership or joint venture, spin-off to shareholders, or other separation transaction for some or all of the businesses within HH&S. Importantly, the Company expects current members of the HH&S leadership team will continue to lead the business in any anticipated outcome.

Pactiv Evergreen Reports First Quarter 2024 Financial Results

First Quarter 2024 Financial Highlights: Net Revenues of $1,252 million for the first quarter of 2024 were down 13% compared to $1,431 million in the first quarter of 2023 and down 2% compared to $1,274 million in the fourth quarter of 2023. Net Income of $10 million for the first quarter of 2024 compared to a net loss of $133 million in the first quarter of 2023 and net income of $22 million in the fourth quarter of 2023.
Back To Top
×Close search
Search